News

Clinical Trials Arena on MSN2d
Sanofi exec tells biotechs not to scrimp on clinical trial design
It is vital for biotech companies to run the right clinical trial and not cut costs with trial design or patient recruitment, ...
Clinical Trials Arena on MSN2d
Patient centricity and effective designs drive clinical trial success
A panel at OCT Europe touched upon where the European clinical trial industry is headed and the impact of technology and ...
Medscape3d
Rituximab’s Role in Systemic Lupus Erythematosus Set for Further Randomized Controlled Trials
Two new RCTs of rituximab will soon begin in the United Kingdom: A biomarker-based trial with add-on belimumab and another in ...
Eyepoint projects DURAVYU Phase 3 enrollment completion by H2 2025 amid strong clinical trial momentum
CEO Jay Duker highlighted the progress of DURAVYU, their lead program for treating wet AMD, noting that over 90% of patients have been randomized in the LUGANO trial and over 50% in the LUCIA trial.
Race and ethnicity often not reported in trials of medications for mental health conditions
A new study led by the University of Southampton has found that the race and ethnicity of participants in clinical trials of medications for mental health and neurodevelopmental conditions often go ...
BlackDoctor.org5d
How Implicit Bias is Keeping Black Americans Out of Clinical Trials
Six ways clinical trial facilitators can address implicit bias against Black Americans and increase Black enrollment.